184 related articles for article (PubMed ID: 32723849)
1. Quantification of Neonatal Fc Receptor and Beta-2 Microglobulin in Human Liver Tissues by Ultraperformance Liquid Chromatography-Multiple Reaction Monitoring-based Targeted Quantitative Proteomics for Applications in Biotherapeutic Physiologically-based Pharmacokinetic Models.
Qiu X; Wang MZ
Drug Metab Dispos; 2020 Oct; 48(10):925-933. PubMed ID: 32723849
[TBL] [Abstract][Full Text] [Related]
2. Tissue expression profile of human neonatal Fc receptor (FcRn) in Tg32 transgenic mice.
Fan YY; Avery LB; Wang M; O'Hara DM; Leung S; Neubert H
MAbs; 2016 Jul; 8(5):848-53. PubMed ID: 27104806
[TBL] [Abstract][Full Text] [Related]
3. Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc Receptor (FcRn) in human tissues and implications for pharmacokinetic modelling.
Barber J; Al-Majdoub ZM; Couto N; Howard M; Elmorsi Y; Scotcher D; Alizai N; de Wildt S; Stader F; Sepp A; Rostami-Hodjegan A; Achour B
Eur J Pharm Sci; 2023 Mar; 182():106375. PubMed ID: 36626943
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Analysis of Human Neonatal Fc Receptor (FcRn) Tissue Expression in Transgenic Mice by Online Peptide Immuno-Affinity LC-HRMS.
Fan YY; Neubert H
Anal Chem; 2016 Apr; 88(8):4239-47. PubMed ID: 27012525
[TBL] [Abstract][Full Text] [Related]
5. Human FcRn Tissue Expression Profile and Half-Life in PBMCs.
Fan YY; Farrokhi V; Caiazzo T; Wang M; O'Hara DM; Neubert H
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31443181
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the human neonatal Fc-receptor alpha-chain in trophoblast-derived BeWo cells increases cellular retention of beta2-microglobulin.
Ellinger I; Reischer H; Lehner C; Leitner K; Hunziker W; Fuchs R
Placenta; 2005; 26(2-3):171-82. PubMed ID: 15708118
[TBL] [Abstract][Full Text] [Related]
7. Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant beta2-microglobulin gene.
Wani MA; Haynes LD; Kim J; Bronson CL; Chaudhury C; Mohanty S; Waldmann TA; Robinson JM; Anderson CL
Proc Natl Acad Sci U S A; 2006 Mar; 103(13):5084-9. PubMed ID: 16549777
[TBL] [Abstract][Full Text] [Related]
8. Calnexin and ERp57 facilitate the assembly of the neonatal Fc receptor for IgG with beta 2-microglobulin in the endoplasmic reticulum.
Zhu X; Peng J; Chen D; Liu X; Ye L; Iijima H; Kadavil K; Lencer WI; Blumberg RS
J Immunol; 2005 Jul; 175(2):967-76. PubMed ID: 16002696
[TBL] [Abstract][Full Text] [Related]
9. The heavy chain of neonatal Fc receptor for IgG is sequestered in endoplasmic reticulum by forming oligomers in the absence of beta2-microglobulin association.
Zhu X; Peng J; Raychowdhury R; Nakajima A; Lencer WI; Blumberg RS
Biochem J; 2002 Nov; 367(Pt 3):703-14. PubMed ID: 12162790
[TBL] [Abstract][Full Text] [Related]
10. Expression of soluble human Neonatal Fc-receptor (FcRn) in Escherichia coli through modification of growth environment.
Ng WK; Lim TS; Lai NS
Protein Expr Purif; 2016 Nov; 127():73-80. PubMed ID: 27412717
[TBL] [Abstract][Full Text] [Related]
11. The neonatal Fc receptor: Key to homeostasic control of IgG and IgG-related biopharmaceuticals.
Baldwin WM; Valujskikh A; Fairchild RL
Am J Transplant; 2019 Jul; 19(7):1881-1887. PubMed ID: 30903736
[TBL] [Abstract][Full Text] [Related]
12. The effect of the neonatal Fc receptor on human IgG biodistribution in mice.
Chen N; Wang W; Fauty S; Fang Y; Hamuro L; Hussain A; Prueksaritanont T
MAbs; 2014; 6(2):502-8. PubMed ID: 24492305
[TBL] [Abstract][Full Text] [Related]
13. Human IgE does not bind to human FcRn.
Brinkhaus M; van der Kooi EJ; Bentlage AEH; Ooijevaar-de Heer P; Derksen NIL; Rispens T; Vidarsson G
Sci Rep; 2022 Jan; 12(1):62. PubMed ID: 34996950
[TBL] [Abstract][Full Text] [Related]
14. Beta 2-microglobulin deficient mice catabolize IgG more rapidly than FcRn- alpha-chain deficient mice.
Kim J; Bronson CL; Wani MA; Oberyszyn TM; Mohanty S; Chaudhury C; Hayton WL; Robinson JM; Anderson CL
Exp Biol Med (Maywood); 2008 May; 233(5):603-9. PubMed ID: 18375831
[TBL] [Abstract][Full Text] [Related]
15. Qualification of a homogeneous cell-based neonatal Fc receptor (FcRn) binding assay and its application to studies on Fc functionality of IgG-based therapeutics.
Mathur A; Arora T; Liu L; Crouse-Zeineddini J; Mukku V
J Immunol Methods; 2013 Apr; 390(1-2):81-91. PubMed ID: 23384837
[TBL] [Abstract][Full Text] [Related]
16. Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice.
Garg A; Balthasar JP
J Pharmacokinet Pharmacodyn; 2007 Oct; 34(5):687-709. PubMed ID: 17636457
[TBL] [Abstract][Full Text] [Related]
17. Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn.
Israel EJ; Wilsker DF; Hayes KC; Schoenfeld D; Simister NE
Immunology; 1996 Dec; 89(4):573-8. PubMed ID: 9014824
[TBL] [Abstract][Full Text] [Related]
18. The neonatal Fc receptor is a pan-echovirus receptor.
Morosky S; Wells AI; Lemon K; Evans AS; Schamus S; Bakkenist CJ; Coyne CB
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3758-3763. PubMed ID: 30808762
[TBL] [Abstract][Full Text] [Related]
19. The multiple facets of FcRn in immunity.
Stapleton NM; Einarsdóttir HK; Stemerding AM; Vidarsson G
Immunol Rev; 2015 Nov; 268(1):253-68. PubMed ID: 26497526
[TBL] [Abstract][Full Text] [Related]
20. A novel in vitro assay to predict neonatal Fc receptor-mediated human IgG half-life.
Souders CA; Nelson SC; Wang Y; Crowley AR; Klempner MS; Thomas W
MAbs; 2015; 7(5):912-21. PubMed ID: 26018774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]